Volume 12, Issue 1 (Winter 2015 -- 2015)                   ASJ 2015, 12(1): 3-8 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karimfar M H, Noorozian M, Mastery Farahani R, Sadat Khoramgah M, Azimi H, Keramatinia A A, et al . Stable Transfection of pEGFP-N1-MOG Plasmid to Utilize in Multiple Sclerosis Gene Therapy. ASJ. 2015; 12 (1) :3-8
URL: http://anatomyjournal.ir/article-1-100-en.html
1- Organization
2- Department of Biology and Anatomical Sciences, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran.
Abstract:   (3958 Views)
Introduction: Multiple sclerosis (MS) is a disease of the immune system: it attacks the myelin around the axons and leaves them exposed. Destruction of myelin weakens the electrical conduction of ions and thus leads to a lack of communication in the nervous system. 
Methods: In the present study, we constructed recombinant plasmid and then transformed to E. coli cell. The colonies containing plasmid were selected by Colony PCR. Enzyme digestion and sequencing were utilized to approve the accuracy of the extracted plasmid of these clones. Recombinant plasmid transfect in to mesanchymal stem cells.
Results: Plasmid was verified correctly. After transfection, the transcription of MOG gene and the expression of MOG protein were proved by RT-PCR, western blotting and Elisa.
Conclusion: Plasmid was constructed correctly and mesenchyme stem cells were successfully transfected by transfection and protein can be expressed well, setting a proper foundation for the future studies on the transplantation of gene modified mesanchymal stem cells in order to promote Multiple sclerosis.
Full-Text [PDF 660 kb]   (1689 Downloads)    
Type of Study: Original |
Received: 2014/08/18 | Accepted: 2014/12/2 | Published: 2015/02/1

Add your comments about this article : Your username or Email:
CAPTCHA code

Send email to the article author


Designed & Developed by : Yektaweb